NEXTHERA CAPITAL LP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
NEXTHERA CAPITAL LP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2019$7,270,000
+13.1%
524,140
+56.6%
6.06%
-22.4%
Q1 2019$6,430,000
-49.6%
334,724
-62.6%
7.80%
+48.3%
Q4 2018$12,767,000
-56.2%
894,679
-36.0%
5.26%
-5.7%
Q3 2018$29,132,000
-7.4%
1,398,577
+5.2%
5.58%
+14.6%
Q2 2018$31,460,000
+99.1%
1,329,104
+22.9%
4.87%
+87.2%
Q1 2018$15,799,000
+141.7%
1,081,410
+167.3%
2.60%
+115.9%
Q4 2017$6,537,000
-41.0%
404,528
-48.9%
1.20%
-57.7%
Q3 2017$11,074,000
+169.7%
792,106
-37.3%
2.85%
+12.9%
Q3 2016$4,106,0001,263,2762.52%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders